The US Deputy Secretary of Health and Human Services stated that federal vaccine guidelines remain flexible and subject to updates as new scientific data emerges. The official emphasized that public health recommendations are not static and must evolve with ongoing research, particularly concerning new variants and long-term efficacy data. This approach involves coordination between agencies like the CDC and NIH, alongside initiatives such as ARPA-H, to continuously evaluate and refine vaccination strategies. The goal is to ensure guidelines are based on the most current evidence to protect public health effectively. Read the full article at: https://www.technologyreview.com/2026/02/13/1132889/us-deputy-health-secretary-vaccine-guidelines-longevity-arpa-h-cdc-nih/